Nalaganje...
Perspective: cancer vaccines in the era of immune checkpoint blockade
Current excitement about cancer immunotherapy is the result of unprecedented clinical impact from immune checkpoint inhibitors, particularly those that target programmed death (PD)-1 and PD-ligand (L)-1. Numerous other immunotherapeutics are also finding their way into the clinic either alone or in...
Shranjeno v:
| izdano v: | Mamm Genome |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267701/ https://ncbi.nlm.nih.gov/pubmed/30446791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00335-018-9786-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|